Related Experiment Video

Updated: May 9, 2026

Ovarian Cancer Patient-Derived Organoid Models for Pre-Clinical Drug Testing
05:35

Ovarian Cancer Patient-Derived Organoid Models for Pre-Clinical Drug Testing

Published on: September 15, 2023

Drug delivery approaches for ovarian cancer therapy

Anastasia Malek1

  • 1Laboratory of Oncoendocrinology, NN Petrov Institute of Oncology, St. Petersburg, Russia.

Methods in Molecular Biology (Clifton, N.J.)
|August 6, 2013
PubMed

Insights

Targeted drug delivery for ovarian cancer is challenging. Intraperitoneal administration offers a promising approach for locoregional delivery of genetic drugs within the peritoneal cavity.

Area of Science:

  • Oncology
  • Pharmacology
  • Biotechnology

Background:

  • Tumor-specific drug delivery faces challenges limiting advanced anticancer therapeutics.
  • Ovarian cancer disseminates within the peritoneal cavity, enabling locoregional administration.
  • Intraperitoneal drug delivery is a viable strategy for ovarian cancer treatment.

Purpose of the Study:

  • To review promising approaches for therapeutic delivery of genetic drugs in ovarian cancer.
  • To highlight the potential of locoregional drug administration for ovarian cancer.
  • To discuss strategies for overcoming challenges in anticancer drug delivery.

Main Methods:

  • Literature review of therapeutic delivery systems for genetic drugs.
  • Analysis of ovarian cancer dissemination patterns.
  • Evaluation of intraperitoneal administration routes.

Main Results:

  • Specific intraperitoneal drug delivery strategies show promise for ovarian cancer.
  • Genetic drugs can be effectively delivered locoregionally within the peritoneal cavity.
  • Advanced therapeutics can potentially overcome delivery limitations.

Conclusions:

  • Intraperitoneal administration is a promising strategy for ovarian cancer genetic drug delivery.
  • Targeted delivery approaches can enhance the efficacy of anticancer therapeutics.
  • Understanding ovarian cancer biology is key to developing effective treatments.

More Related Videos

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model09:02

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model

Published on: September 27, 2024

Evaluating the Angiogenetic Properties of Ovarian Cancer Stem-Like Cells using the Three-Dimensional Co-Culture System, NICO-107:59

Evaluating the Angiogenetic Properties of Ovarian Cancer Stem-Like Cells using the Three-Dimensional Co-Culture System, NICO-1

Published on: December 5, 2020

Related Concept Videos

Drug Delivery Systems: Different Types01:27

Drug Delivery Systems: Different Types

Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
Drug Delivery: Miscellaneous Routes01:22

Drug Delivery: Miscellaneous Routes

Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection,  and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Drug Delivery: Overview01:16

Drug Delivery: Overview

The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...